News
Tripoint will commercialize SPARC's Elepsia XR tablets for five years, with the option to extend the agreement further.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback